Imamura Teruhiko, Chung Ben, Nguyen Ann, Rodgers Daniel, Sayer Gabriel, Adatya Sirtaz, Sarswat Nitasha, Kim Gene, Raikhelkar Jayant, Ota Takeyohi, Song Tae, Juricek Colleen, Kagan Viktoriya, Jeevanandam Valluvan, Mehra Mandeep, Burkhoff Daniel, Uriel Nir
From the Department of Medicine (T.I., B.C., A.N., D.R., G.S., S.A., N.S., G.K., J.R., N.U.) and Department of Surgery (T.O., T.S., C.J., V.K., V.J.), University of Chicago Medical Center, IL; Department of Medicine, Brigham and Women's Hospital, Boston, MA (M.M.); and Columbia University Medical Center, Cardiovascular Research Foundation, New York, NY (D.B.).
Circ Heart Fail. 2017 Sep;10(9). doi: 10.1161/CIRCHEARTFAILURE.117.003882.
A cohort of heart failure (HF) patients receiving left ventricular assist devices (LVADs) has decoupling of their diastolic pulmonary artery pressure and pulmonary capillary wedge pressure. However, the clinical implications of this decoupling remain unclear.
In this prospective study, patients with LVADs underwent routine invasive hemodynamic ramp testing with right heart catheterization, during which LVAD speeds were adjusted. Inappropriate decoupling was defined as a >5 mm Hg difference between diastolic pulmonary artery pressure and pulmonary capillary wedge pressure. The primary outcomes of survival and heart failure readmission rates after ramp testing were assessed. Among 63 LVAD patients (60±12 years old and 25 female [40%]), 27 patients (43%) had inappropriate decoupling at their baseline speed. After adjustment of their rotation speed during ramp testing, 30 patients (48%) had inappropriate decoupling. Uni/multivariable Cox analyses demonstrated that decoupling was the only significant predictor for the composite end point of death and heart failure readmission during the 1 year following the ramp study (total of 18 events; hazards ratio, 1.09; 95% confidence interval, 1.04-1.24; <0.05). Furthermore, normalization of decoupling (n=8) during ramp testing was significantly associated with higher 1-year heart failure readmission-free survival rate compared with the non-normalized group (n=19, 100% versus 53%; =0.035).
The presence of inappropriate decoupling was associated with worse outcomes in patients with LVADs. Prospective, large-scale multicenter studies to validate the result are warranted.
一组接受左心室辅助装置(LVAD)的心力衰竭(HF)患者,其舒张期肺动脉压与肺毛细血管楔压出现解耦。然而,这种解耦的临床意义仍不明确。
在这项前瞻性研究中,LVAD患者接受了右心导管插入术的常规有创血流动力学斜坡试验,在此期间调整LVAD速度。不适当解耦定义为舒张期肺动脉压与肺毛细血管楔压之间相差>5 mmHg。评估斜坡试验后生存和心力衰竭再入院率的主要结局。在63例LVAD患者(60±12岁,25例女性[40%])中,27例患者(43%)在基线速度时存在不适当解耦。在斜坡试验期间调整其转速后,30例患者(48%)存在不适当解耦。单/多变量Cox分析表明,解耦是斜坡研究后1年内死亡和心力衰竭再入院复合终点的唯一显著预测因素(共18例事件;风险比,1.09;95%置信区间,1.04 - 1.24;P<0.05)。此外,与未归一化组(n = 19)相比,斜坡试验期间解耦归一化(n = 8)与更高的1年无心力衰竭再入院生存率显著相关(100%对53%;P = 0.035)。
不适当解耦的存在与LVAD患者的较差结局相关。有必要进行前瞻性、大规模多中心研究以验证该结果。